Sublimity Therapeutics
Dublin
About Sublimity Therapeutics
Sublimity Therapeutics (formerly Sigmoid Pharma), is a specialty pharma company with offices in Dublin, Ireland, and Solana Beach, California. Sublimity’s goal is to identify and create meaningful new therapies for unmet clinical needs in gastrointestinal and immunological diseases. Sublimity’s priority focus is on its lead product, STI-0529, for treatment of moderate to severe ulcerative colitis.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $70.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2020)
- Website: sublimitytherapeutics.com
- Phone: (353) 170-0751
Industries & Categories
Biotechnology, Delivery, Health Care, Pharmaceutical, Wellness
Social Profiles
Canonical: https://fsome.com/organization/sublimity-therapeutics-16539 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.